These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25047712)

  • 21. Structure and reaction mechanism of phosphoethanolamine methyltransferase from the malaria parasite Plasmodium falciparum: an antiparasitic drug target.
    Lee SG; Kim Y; Alpert TD; Nagata A; Jez JM
    J Biol Chem; 2012 Jan; 287(2):1426-34. PubMed ID: 22117061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimerization of Arginyl-tRNA Synthetase by Free Heme Drives Its Inactivation in Plasmodium falciparum.
    Jain V; Yogavel M; Sharma A
    Structure; 2016 Sep; 24(9):1476-87. PubMed ID: 27502052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competitive Inhibition of Okanin against
    Yang G; Liang Y; Li X; Li Z; Qin Y; Weng Q; Yan Y; Cheng Y; Qian Y; Sun L
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Adaptive Proline Response in P. falciparum Is Independent of PfeIK1 and eIF2α Signaling.
    Fagbami L; Deik AA; Singh K; Santos SA; Herman JD; Bopp SE; Lukens AK; Clish CB; Wirth DF; Mazitschek R
    ACS Infect Dis; 2019 Apr; 5(4):515-520. PubMed ID: 30773881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo.
    Novoa EM; Camacho N; Tor A; Wilkinson B; Moss S; Marín-García P; Azcárate IG; Bautista JM; Mirando AC; Francklyn CS; Varon S; Royo M; Cortés A; Ribas de Pouplana L
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):E5508-17. PubMed ID: 25489076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Aminoacyl tRNA Synthetases for Antimalarial Drug Development.
    Xie SC; Griffin MDW; Winzeler EA; Ribas de Pouplana L; Tilley L
    Annu Rev Microbiol; 2023 Sep; 77():111-129. PubMed ID: 37018842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural analysis of malaria-parasite lysyl-tRNA synthetase provides a platform for drug development.
    Khan S; Garg A; Camacho N; Van Rooyen J; Kumar Pole A; Belrhali H; Ribas de Pouplana L; Sharma V; Sharma A
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):785-95. PubMed ID: 23633587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a novel prolyl-tRNA synthetase inhibitor and elucidation of its binding mode to the ATP site in complex with l-proline.
    Adachi R; Okada K; Skene R; Ogawa K; Miwa M; Tsuchinaga K; Ohkubo S; Henta T; Kawamoto T
    Biochem Biophys Res Commun; 2017 Jun; 488(2):393-399. PubMed ID: 28501621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic analyses of aminoacyl tRNA synthetases from human-infecting helminths.
    Goel P; Parvez S; Sharma A
    BMC Genomics; 2019 May; 20(1):333. PubMed ID: 31046663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis of malaria parasite lysyl-tRNA synthetase inhibition by cladosporin.
    Khan S; Sharma A; Belrhali H; Yogavel M; Sharma A
    J Struct Funct Genomics; 2014 Jun; 15(2):63-71. PubMed ID: 24935905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Basis for Specific Inhibition of tRNA Synthetase by an ATP Competitive Inhibitor.
    Fang P; Han H; Wang J; Chen K; Chen X; Guo M
    Chem Biol; 2015 Jun; 22(6):734-44. PubMed ID: 26074468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminoacyl-tRNA Synthetases as Valuable Targets for Antimicrobial Drug Discovery.
    Pang L; Weeks SD; Van Aerschot A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmodium falciparum mitochondria import tRNAs along with an active phenylalanyl-tRNA synthetase.
    Sharma A; Sharma A
    Biochem J; 2015 Feb; 465(3):459-69. PubMed ID: 25391660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards Novel 3-Aminopyrazinamide-Based Prolyl-tRNA Synthetase Inhibitors: In Silico Modelling, Thermal Shift Assay and Structural Studies.
    Pang L; Weeks SD; Juhás M; Strelkov SV; Zitko J; Van Aerschot A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-guided conversion from an anaplastic lymphoma kinase inhibitor into Plasmodium lysyl-tRNA synthetase selective inhibitors.
    Zhou J; Xia M; Huang Z; Qiao H; Yang G; Qian Y; Li P; Zhang Z; Gao X; Jiang L; Wang J; Li W; Fang P
    Commun Biol; 2024 Jun; 7(1):742. PubMed ID: 38890421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as
    Okaniwa M; Shibata A; Ochida A; Akao Y; White KL; Shackleford DM; Duffy S; Lucantoni L; Dey S; Striepen J; Yeo T; Mok S; Aguiar ACC; Sturm A; Crespo B; Sanz LM; Churchyard A; Baum J; Pereira DB; Guido RVC; Dechering KJ; Wittlin S; Uhlemann AC; Fidock DA; Niles JC; Avery VM; Charman SA; Laleu B
    ACS Infect Dis; 2021 Jun; 7(6):1680-1689. PubMed ID: 33929818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.
    Baragaña B; Forte B; Choi R; Nakazawa Hewitt S; Bueren-Calabuig JA; Pisco JP; Peet C; Dranow DM; Robinson DA; Jansen C; Norcross NR; Vinayak S; Anderson M; Brooks CF; Cooper CA; Damerow S; Delves M; Dowers K; Duffy J; Edwards TE; Hallyburton I; Horst BG; Hulverson MA; Ferguson L; Jiménez-Díaz MB; Jumani RS; Lorimer DD; Love MS; Maher S; Matthews H; McNamara CW; Miller P; O'Neill S; Ojo KK; Osuna-Cabello M; Pinto E; Post J; Riley J; Rottmann M; Sanz LM; Scullion P; Sharma A; Shepherd SM; Shishikura Y; Simeons FRC; Stebbins EE; Stojanovski L; Straschil U; Tamaki FK; Tamjar J; Torrie LS; Vantaux A; Witkowski B; Wittlin S; Yogavel M; Zuccotto F; Angulo-Barturen I; Sinden R; Baum J; Gamo FJ; Mäser P; Kyle DE; Winzeler EA; Myler PJ; Wyatt PG; Floyd D; Matthews D; Sharma A; Striepen B; Huston CD; Gray DW; Fairlamb AH; Pisliakov AV; Walpole C; Read KD; Van Voorhis WC; Gilbert IH
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7015-7020. PubMed ID: 30894487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoacyl-tRNA synthetase inhibition activates a pathway that branches from the canonical amino acid response in mammalian cells.
    Kim Y; Sundrud MS; Zhou C; Edenius M; Zocco D; Powers K; Zhang M; Mazitschek R; Rao A; Yeo CY; Noss EH; Brenner MB; Whitman M; Keller TL
    Proc Natl Acad Sci U S A; 2020 Apr; 117(16):8900-8911. PubMed ID: 32253314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro resistance selections for Plasmodium falciparum dihydroorotate dehydrogenase inhibitors give mutants with multiple point mutations in the drug-binding site and altered growth.
    Ross LS; Gamo FJ; Lafuente-Monasterio MJ; Singh OM; Rowland P; Wiegand RC; Wirth DF
    J Biol Chem; 2014 Jun; 289(26):17980-95. PubMed ID: 24782313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the biology and drug targeting of malaria parasite aminoacyl-tRNA synthetases.
    Khan S
    Malar J; 2016 Apr; 15():203. PubMed ID: 27068331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.